Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA in Women With Poor Ovarian Reserve Undergoing IVF
NCT02099916Phase 3Unknown
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Oct 2014
- Primary completion
- Dec 2014
01
Overview
Phase 3, randomised, open-label trial of dehydroepiandrosterone in Diminished Ovarian Reserve (DOR), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Clinical Pregnancy Rate at 18 months. Status: unknown.
02
Drugs
dehydroepiandrosterone
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT02099916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099916.